Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-19 1:01 pm Purchase | 2026-05-15 | 13D | VIVANI MED INC VANI | Williams Gregg | 43,218,419 47.100% | 19,621,290 (+83.15%) | Filing History |
| 2023-05-01 8:42 pm Purchase | 2023-04-27 | 13D | VIVANI MED INC VANI | Williams Gregg | 23,597,129 38.900% | 2,687,509 (+12.85%) | Filing History |
| 2023-04-25 5:28 pm Purchase | 2023-04-25 | 13D | VIVANI MED INC VANI | Bolck Joachim Eberhard | 5,597,123 11.030% | 5,597,123 (New Position) | Filing History |
| 2022-09-01 9:34 pm Purchase | 2022-08-30 | 13D | SECOND SIGHT MEDICAL PRODUCTS EYES | Williams Gregg | 20,909,620 41.220% | 15,145,060 (+262.73%) | Filing History |
| 2022-08-31 6:49 pm Purchase | 2022-08-30 | 13D | VIVANI MED INC VANI | Mendelsohn Adam | 3,712,573 7.510% | 3,712,573 (New Position) | Filing History |
| 2022-07-22 5:06 pm Purchase | 2022-05-18 | 13D | SECOND SIGHT MEDICAL PRODUCTS EYES | Williams Gregg | 5,764,560 38.060% | 457,654 (+8.62%) | Filing History |
| 2022-01-13 10:36 am Sale | 2021-12-31 | 13G | SECOND SIGHT MED PRODS INC EYES | Empery Asset Management LP | 0 0.000% | -1,100,000 (Position Closed) | Filing History |
| 2021-06-28 10:01 am Purchase | 2021-06-22 | 13G | SECOND SIGHT MED PRODS INC EYES | Empery Asset Management LP | 1,100,000 8.710% | 1,100,000 (New Position) | Filing History |